Cargando…
A Variant of TNFR2-Fc Fusion Protein Exhibits Improved Efficacy in Treating Experimental Rheumatoid Arthritis
Etanercept, a TNF receptor 2-Fc fusion protein, is currently being used for the treatment of rheumatoid arthritis (RA). However, 25% to 38% of patients show no response which is suspected to be partially due to insufficient affinity of this protein to TNFα. By using computational protein design, we...
Autores principales: | Yang, Tong, Wang, Zheng, Wu, Fang, Tan, Jingwei, Shen, Yijun, Li, Erguang, Dai, Jingzhi, Shen, Ronghai, Li, Gang, Wu, Jinsong, Wang, Luochun, Wang, Haibo, Liu, Yanjun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816690/ https://www.ncbi.nlm.nih.gov/pubmed/20140191 http://dx.doi.org/10.1371/journal.pcbi.1000669 |
Ejemplares similares
-
T0001, a variant of TNFR2-Fc fusion protein, exhibits improved Fc effector functions through increased binding to membrane-bound TNFα
por: Shen, Yijun, et al.
Publicado: (2017) -
Efficacy of methotrexate and etanercept biosimilar rhTNFR:Fc in Chinese patients with active rheumatoid arthritis: A controlled, randomized and multicenter study
por: Wu, Qingjun, et al.
Publicado: (2020) -
Structural insight and stability of TNFR-Fc fusion protein (Etanercept) produced by using transgenic silkworms
por: Kiyoshi, Masato, et al.
Publicado: (2020) -
OX40-Fc Fusion Protein Alleviates PD-1-Fc-Aggravated Rheumatoid Arthritis by Inhibiting Inflammatory Response
por: Huang, Yanyan, et al.
Publicado: (2022) -
Regulation of T Cell Activities in Rheumatoid Arthritis by the Novel Fusion Protein IgD-Fc-Ig
por: Zhang, Jing, et al.
Publicado: (2020)